Host and viral factors in relation to clearance of human papillomavirus infection: A cohort study in Taiwan

被引:37
作者
Lai, Chyong-Huey [1 ,2 ]
Chao, Angel [2 ]
Chang, Chee-Jen [3 ]
Chao, Fang-Yu [2 ]
Huang, Huei-Jean [2 ]
Hsueh, Swei [2 ,4 ]
Lin, Cheng-Tao [2 ]
Cheng, Hui-Hsin [2 ]
Huang, Chu-Chun [2 ]
Yang, Jung-Erh [2 ]
Wu, Tzu-I [2 ]
Chou, Hung-Hsueh [2 ]
Chang, Ting-Chang [2 ]
机构
[1] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Obstet & Gynecol, Tao Yuan 333, Taiwan
[2] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan
[3] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan
[4] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan 333, Taiwan
关键词
human papillomavirus; genotype; viral load; clearance;
D O I
10.1002/ijc.23679
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human papillomavirus (HPV) persistence is essential for cervical cancer development. We accrued nested-cohort subjects front a population-based study to investigate the host and viral factors related to outcome of HPV infection. Women (age : 30 years old) with HPV-posilive but normal cytology and negative colposcopy were invited to participate. After signing informed consent, every participant completed a structured questionnaire and had 6-monthly follow-ups of Pal) smear, HPV testing and colposcopy. Total and type-specific HPV clearance rates as well as host and viral factors associated with clearance in 3-year longitudinal followup were analyzed. Adjusted hazard ratios (HRs) of progression to >= cervical intraepithelial neoplasia (CIN) 2 according to baseline HPV of the women with normal cytology were calculated from national registry database. Among the 626 eligible women, 526 (median age 47, 29-75) were enrolled and 412 returned for followup at least once. The median follow-up of enrolled subjects was 23 months (range 6.8-39). The 3-year cumulative total HPV clearance rate was 49.0% (95% confidence interval [CI]: 43.3-54.7%). The median 3-year cumulative type-specific HPV clearance rate was 50.0% (range 0-100.0%) with a median time to clearance of 12.4 months (6.4-24.5). Older age was associated with significantly decreased total HPV clearance and decreased type-specific clearance in HPV-18 and -53, while high viral load was associated with decreased total and type-specific clearance. After adjusting confounding variables, the FIR of developing >= CIN2 in baseline HPV-positive women was 34.0-fold (95% Cl: 15.3-74.7) as compared to HPV-negative women. (C) 2008 Wiley-Liss, hic.
引用
收藏
页码:1685 / 1692
页数:8
相关论文
共 34 条
[1]   Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women [J].
Aho, J ;
Hankins, C ;
Tremblay, C ;
Forest, P ;
Pourreaux, K ;
Rouah, F ;
Coutlée, F .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (01) :46-52
[2]  
American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V105, P905
[3]   High-risk HPV type-specific clearance rates in cervical screening [J].
Bulkmans, N. W. J. ;
Berkhof, J. ;
Bulk, S. ;
Bleeker, M. C. G. ;
van Kemenade, F. J. ;
Rozendaal, L. ;
Snijders, P. J. F. ;
Meijer, C. J. L. M. .
BRITISH JOURNAL OF CANCER, 2007, 96 (09) :1419-1424
[4]  
Castle PE, 2002, JNCI-J NATL CANCER I, V94, P1406, DOI 10.1093/jnci/94.18.1406
[5]   Detection and quantitation of human papillomavirus DNA in primary tumour and lymph nodes of patients with early stage cervical carcinoma [J].
Chan, PKS ;
Yu, MMY ;
Cheung, TH ;
To, KF ;
Lo, KWK ;
Cheung, JLK ;
Tong, JHM .
JOURNAL OF CLINICAL VIROLOGY, 2005, 33 (03) :201-205
[6]   Cervical cancer screening program integrating Pap smear and HPV DNA testing: A population-based study [J].
Chao, Angel ;
Hsu, Kuang-Hung ;
Lai, Chyong-Huey ;
Huang, Huei-Jean ;
Hsueh, Swei ;
Lin, Sheue-Rong ;
Jung, Shih-Ming ;
Chao, Fang-Yu ;
Huang, Shang-Lang ;
Huang, Chu-Chun ;
Yang, Jung-Erh ;
Chang, Ting-Chang .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (12) :2835-2841
[7]   Worldwide distribution of human papillomavirus types in cytologically normal women in the international Agency for Research on Cancer HPV prevalence surveys:: a pooled analysis [J].
Clifford, GM ;
Gallus, S ;
Herrero, R ;
Muñoz, N ;
Snijders, PJF ;
Vaccarella, S ;
Anh, PTH ;
Ferreccio, C ;
Hieu, NT ;
Matos, E ;
Molano, M ;
Rajkumar, R ;
Ronco, G ;
de Sanjosé, S ;
Shin, HR ;
Sukvirach, S ;
Thomas, JO ;
Tunsakul, S ;
Meijer, CJLM ;
Franceschi, S .
LANCET, 2005, 366 (9490) :991-998
[8]   Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study [J].
Cuschieri, KS ;
Cubie, HA ;
Whitley, MW ;
Gilkison, G ;
Arends, MJ ;
Graham, C ;
McGoogan, E .
JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (09) :946-950
[9]   HUMAN PAPILLOMAVIRUS TESTING IN PRIMARY CERVICAL SCREENING [J].
CUZICK, J ;
SZAREWSKI, A ;
TERRY, G ;
HO, L ;
HANBY, A ;
MADDOX, P ;
ANDERSON, M ;
KOCJAN, G ;
STEELE, ST ;
GUILLEBAUD, J .
LANCET, 1995, 345 (8964) :1533-1536
[10]   Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer [J].
Franco, EL ;
Villa, LL ;
Sobrinho, JP ;
Prado, JM ;
Rousseau, MC ;
Désy, M ;
Rohan, TE .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (05) :1415-1423